Quantum Computing is incredible. It’s probably my favorite technology innovation of all time, and that’s saying a lot because I’ve had a great career as a technologist, and a lot of fun as an amateur magician.
Why Quantum Computing? I think Quantum Computing is magical because it has this incredible power and potential that is based upon complex, nearly invisible quantum mechanics. And if that isn’t cool enough, there has been so much technological innovation recently in this field that we are on the cusp of introducing completely new paradigms in business and technology.
Quantum is going to open the doors for businesses to tackle problems they never dreamed they could tackle—and at speeds they never dreamed possible! Let me tell you, I believe that quantum is going to make impossible things possible.
In Accenture Labs, we love tackling the impossible—and we love to dream big and invent big things. That’s why over a year ago, we started working on Quantum Computing. I’ve been involved in several of our research efforts and pilots, and we’ve been doing some great things with companies, including 1Qbit, a quantum software innovator, to explore use cases where quantum can be applied today to set a foundation for the future.
This is very aligned to our R&D work in Accenture Labs; our intention and mission is to help clients across many industries identify the right quantum opportunities and start working with quantum now so that they’ll be ahead of the curve. And to be honest with you, it’s been hard for me to keep this secret about the great work we’ve been doing.
That’s why today, I’m VERY excited to finally announce one of our great collaborations. We’ve been teaming with Biogen, Accenture Life Sciences industry group and 1Qbit to do some pretty amazing work. We have researched together to achieve a very significant breakthrough—we were able to verify the speed and accuracy of the Quantum method for molecular comparison
Why is this exciting? I’ll tell you! This is taking another significant step towards improving the pharmaceutical industry’s drug discovery and design process, which is going to help provide better outcomes for patients.
In just two months, Accenture Labs collaborated with Quantum software provider 1QBit, and we created a first-of-its-kind Quantum-enabled molecular comparison application. This application could significantly improve advanced molecular design. It will increase the speed of drug discovery for very complex neurological conditions like multiple sclerosis, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease. Biogen now has a new Quantum-enabled application that is going to help it create molecular comparison results that give much deeper insights about shared genetic traits.
This is just the beginning for Accenture Labs in Quantum! In the coming weeks and months, you’ll be hearing more about Accenture’s work in Quantum Computing, so keep watching. We’re going to share a lot more, including helping clients to understand the field, identify business use cases and apply it now through software APIs. I’d love to hear your feedback!